A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Femasys Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 40,968 shares of FEMY stock, worth $67,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,968
Holding current value
$67,187
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.87 - $1.36 $35,642 - $55,716
40,968 New
40,968 $44,000

Others Institutions Holding FEMY

About FEMASYS INC


  • Ticker FEMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 11,813,600
  • Market Cap $19.4M
  • Description
  • Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support...
More about FEMY
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.